ADMA Biologics Competitors and Similar CompaniesClear all
ADMA Biologics's competitors and similar companies include Longboard Pharmaceuticals and Array BioPharma.
 ADMA Biologics ADMA Biologics develops plasma-based biologics for the treatment and prevention of certain infectious diseases. |  Longboard Pharmaceuticals Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases. |  Array BioPharma Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer. | |
Founding Date | Founding Date 2004 | Founding Date 2020 | Founding Date 1998 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Ramsey, US HQ Boca Raton, US | Locations San Diego, US HQ San Diego, US | Locations Boulder, US HQ Chicago, US Detroit, US Houston, US Miami, US New York, US Phoenix, US |
Employees | Employees 313 | Employees 5056% increase | Employees 110 |
Valuation ($) | Valuation ($) 3.9 b | Valuation ($) 2.3 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $510.2m (FY, 2025) | Revenue (est.) N/A | Revenue (est.) $173.8m (FY, 2018) |
Cost of goods | Cost of goods $217.4m (FY, 2025) | Cost of goods N/A | Cost of goods $59.4m (FY, 2018) |
Gross profit | Gross profit $292.8m (FY, 2025) | Gross profit N/A | Gross profit $114.4m (FY, 2018) |
Net income | Net income $146.9m (FY, 2025) | Net income ($54.4m) (FY, 2023) | Net income ($147.7m) (FY, 2018) |
Funding | |||
Total funding raised | Total funding raised $ 20m | Total funding raised $ 56m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Longboard Pharmaceuticals
HQ
San Diego, US
Employees
50
Longboard Pharmaceuticals, Inc. (Longboard) is a biopharmaceutical company focused on developing transformative medicines for neurological diseases.
View companyArray BioPharma
HQ
Boulder, US
Array BioPharma is focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.
View company